Over 108,000 lawsuits have been filed against manufacturers of transvaginal networks, also known as pelvic networks. These devices, which are surgical implants designed to treat problems like pelvic organ prolapse and stress urinary incontinence, have been claimed to cause a variety of problems, including pain, bleeding, organ damage, perforations, infections, autoimmune problems, and more.
Manufacturers who have been brought to justice for transvaginal network violations include Ethicon (and parent company Johnson & Johnson), C.R. Bard, Boston Scientific, Neomedic International, and Caldera Medical. Tens of thousands of cases have been filed and resolved, but there are still thousands in court and more are expected to be raised in the future.
About Transvaginal Mesh
Also known as vaginal mesh or pelvic mesh products, these products are surgically implanted devices used to treat problems such as pelvic organ prolapse and stress urinary incontinence. With the additional support of weakened tissue, the network is said to improve the symptoms associated with these problems.
However, medical studies have shown that transvaginal mesh products have a much higher complication rate than previously thought. This was particularly due to the fact that the network is at risk of erosion and failure, which can then lead to a large number of injuries.
Affected products are Gynecare, Gynemesh, Ethicon, Avaulta, Pelvicol, Pelvisoft, Spar, Monarc, Perigäum, Elevat, Mentor-Aris, Suspend, T-Sling, Novasilk and Restorelle. Failures and resulting injuries have been reported for all of the above and many other products. If a transvaginal network has been implanted in you or a loved one and you have been injured as a result, you may be entitled to a claim.
The Health Risks of Transvaginal Mesh
Technically, any patient who has had a transvaginal network implanted and has since been shown to have serious health risks could potentially have a legal right. However, claims with specific damages are more successful in court.
Previously successful transvaginal network complaints have shown that the devices can cause organ damage, such as: B. intestinal perforation, infection of the place where the implant is located, pain during intercourse, vaginal scars, urinary problems, recurrence of vaginal prolapse and much more.
The symptoms of these problems can include bleeding, severe pain, infections, autoimmune problems, incontinence, and more. These health problems can be serious, especially with infections that are at risk of spreading across the body and being fatal.
Allegations of transvaginal network lawsuits
Many of the allegations against the manufacturers of transvaginal network products accuse them of false and misleading information about the safety of the devices and violate their legal obligation to ensure their effectiveness.
Manufacturers have been accused of misleading the FDA or the U.S. Food and Drug Administration, its medical industry customers, patients and the public about the safety of the product. Additional allegations were made that products were not tested, side effects and risks were not tested, and no safe methods for removing the devices were developed.
Examples of transvaginal network lawsuits
Ethicon and its parent company Johnson & Johnson have been the subject of more lawsuits related to vaginal networks than any other manufacturer. The highest single lawsuit of $ 57.1 million in 2017 was awarded by a Philadelphia jury to Ella Ebaugh, who suffered from chronic pain and urinary incontinence after two Ethicon pelvic mesh implants were eroded into her urethra and they performed three surgeries had to remove the network.
Meanwhile, Johnson & Johnson agreed to a $ 120 million agreement between 2000 and 3000 applicants in January 2016. However, this is still only part of the cases the company faces.
C. R. Bard has also resolved many cases, including paying an applicant $ 68 million and resolving over 3,000 cases for a total of $ 200 million. At the time of their last settlement, C. R. Bard is still facing over 10,000 unsolved cases.
Boston Scientific is currently facing more than 20,000 network lawsuits and, in May 2015, awarded $ 100 million to a woman equipped with her Pinnacle and Advantage Fit network products. This is the largest single judgment that has ever been paid in a transvaginal online lawsuit.
There are still thousands of cases that have not yet been resolved in court, and studies have shown that it is far more likely that more people will be injured by transvaginal networks in the future. Currently, a total of over $ 5 billion has been paid to applicants. We could only name a few examples, but many other companies, including Neomedic Coloplast and Endo / American Medical Systems, had to pay out millions of patients equipped with their transvaginal network products.
Are transvaginal network products still on the market?
As of April 16, 2019, no new transvaginal network products will be sold on the market. This is the date on which the FDA asked Boston Scientific and Coloplast to immediately stop marketing their products and ordered them to remove any remaining products from the market.
Therefore, no transvaginal network products are legally available on the market. However, there can still be thousands of women who have had these products implanted but who do not yet have any adverse side effects. If someone with a transvaginal network hurts them in the future, they can file a lawsuit against the manufacturers.
The latest with transvaginal mesh products
Although no manufacturer has legally sold or marketed transvaginal mesh products in the United States, there are still many patients who have had such products implanted. Anyone with a transvaginal network should be well aware of the health risks they pose and consider seeing their doctor for the slightest signs of pain, incontinence, bleeding, or other symptoms associated with these products.
All women with transvaginal meshes are entitled to file a lawsuit against their manufacturer. However, it can be more difficult to successfully file a lawsuit without having to claim certain damages.